Ensayos clínicos

PYRUVATE KINASE DEFICIENCY GLOBAL LONGITUDINAL REGISTRY (AG348-C-008 OBS DPK)

Centro: Hospital Universitario Vall de Hebrón (Barcelona) y Hospital Universitario La Paz (Madrid)
Contacto: Dr. David Beneitez (H. Vall de Hebrón), Dra. Marta Morado (H.Universitario La Paz)

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO
EVALUATE THE EFFICACY AND SAFETY OF AG-348 IN NOT REGULARLY TRANSFUSED
ADULT SUBJECTS WITH PYRUVATE KINASE DEFICIENCY (AG348-C-006 F III DPK)

Centro: Hospital Universitario Vall de Hebrón (Barcelona) y Hospital Universitario La Paz (Madrid)
Contacto: Dr. David Beneitez (H. Vall de Hebrón), Dra. Marta Morado (H.Universitario La Paz)

AN OPEN-LABEL, MULTICENTER, EXTENSION STUDY OF AG-348 IN ADULT
SUBJECTS WITH PYRUVATE KINASE DEFICIENCY PREVIOUSLY ENROLLED IN AG-348
STUDIES (AG348-C-011 FIII EXTENSIÓN DPK)

Centro: Hospital Universitario Vall de Hebrón (Barcelona) y Hospital Universitario La Paz (Madrid)
Contacto: Dr. David Beneitez (H. Vall de Hebrón), Dra. Marta Morado (H.Universitario La Paz)

lentiviral-mediated gene therapy of fanconi anemia patients subtype a (fancolen-1)

Centro: Hospital infantil Universitario Niño Jesus, Madrid, Spain
Contacto: Julian Sevilla

paricalcitol improves anemia of inflamation (pieraid)

Centro: Hospital Sin Espases, Mallorca
Contacto: Miguel Giovanni Uriol Rivera

USEFULNESS OF FECAL IMMUNOCHEMICAL TEST IN IRON DEFICIENCY ANEMIA (IDAFIT) (IDAFIT)

Centro: Hospital Universitario de Canarias

EFFECTS OF IRON THERAPY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION AND IRON DEFICIENCY (PREFER-HF) (PREFER-HF)

Centro: Institut de Recerca Biomèdica de Lleida
Contacto: José Luis Morales Rull, MD, PhD.

ELTROMBOPAG COMBINED WITH CYCLOSPORINE AS FIRST LINE THERAPY IN PATIENTS WITH SEVERE ACQUIRED APLASTIC ANEMIA (SOAR)

Centro: San Sebastián, Madrid.

EFFICACY AND SAFETY OF FG-4592 FOR TREATMENT OF ANEMIA IN PATIENTS WITH LOWER RISK MDS WITH LOW RED BLOOD CELL TRANSFUSION BURDEN

Centro: Investigational Site Recruiting, Sabadell, Barcelona, Spain, 08208 / Investigational Site Recruiting, Barcelona, Catalunya, Spain, 08003 / Investigational Site Recruiting, Pamplona, Navarra, Spain, 31008 / Investigational Site Recruiting, Barcelona, Spain, 08041 / Investigational Site Recruiting, Madrid, Spain, 28034 / Investigational Site Recruiting
Sevilla, Spain, 41009 / Investigational Site Recruiting Sevilla, Spain, 41013

EFFICACY AND SAFETY STUDY OF LUSPATERCEPT (ACE-536) VERSUS EPOETIN ALFA FOR THE TREATMENT OF ANEMIA DUE TO IPSS-R VERY LOW, LOW OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES (MDS) IN ESA NAÏVE SUBJECTS WHO REQUIRE RED BLOOD CELL TRANSFUSIONS (COMMANDS)

Centro: Instituto Catalan de Oncologia-Hospital Duran i Reynals Not yet recruiting, Barcelona, Spain, 08908 / Hospital Universitari Vall d’Hebron Not yet recruiting, Barcelona, Spain, 8035 / Hospital Virgenes de las Nieves Not yet recruiting, Granada, Spain, 18014 / Hospital General Universitario Gregorio Maranon Not yet recruiting, Madrid, Spain, 28007 / Hospital Universitario 12 de Octubre Not yet recruiting, Madrid, Spain, 28041 / Hospital Universitario Virgen De La Victoria Not yet recruiting, Malaga, Spain, 29010 / C. H. de Orense Not yet recruiting, Ourense, Spain, 32005 / Hospital Universitario de Salamanca Not yet recruiting, Salamanca, Spain, 37007 / Hospital Clinico Universitario de Valencia Not yet recruiting, Valencia, Spain, 46010 / Hospital Universitari i Politecnic La Fe de Valencia Not yet recruiting, Valencia, Spain, 46026

Curso anual del grupo español de eritropatología

PROFUNDIZAR EN EL CONOCIMIENTO

más información